A detailed history of Duncker Streett & CO Inc transactions in Baxter International Inc stock. As of the latest transaction made, Duncker Streett & CO Inc holds 1,801 shares of BAX stock, worth $59,991. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,801
Previous 1,801 -0.0%
Holding current value
$59,991
Previous $60,000 13.33%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

SELL
$39.98 - $47.68 $11,274 - $13,445
-282 Reduced 13.54%
1,801 $82,000
Q1 2023

Apr 24, 2023

SELL
$37.58 - $52.57 $18,564 - $25,969
-494 Reduced 19.17%
2,083 $84,000
Q3 2022

Nov 04, 2022

SELL
$53.86 - $66.8 $60,484 - $75,016
-1,123 Reduced 30.35%
2,577 $139,000
Q4 2021

Feb 08, 2022

BUY
$74.57 - $87.19 $18,642 - $21,797
250 Added 7.25%
3,700 $318,000
Q3 2021

Nov 03, 2021

BUY
$73.77 - $83.61 $14,754 - $16,722
200 Added 6.15%
3,450 $277,000
Q2 2021

Jul 27, 2021

BUY
$80.5 - $88.01 $16,100 - $17,602
200 Added 6.56%
3,250 $262,000
Q4 2020

Feb 02, 2021

SELL
$75.39 - $82.36 $64,458 - $70,417
-855 Reduced 21.9%
3,050 $245,000
Q3 2020

Oct 28, 2020

SELL
$78.33 - $90.73 $251,987 - $291,878
-3,217 Reduced 45.17%
3,905 $314,000
Q1 2020

Apr 27, 2020

SELL
$71.57 - $93.3 $7,156 - $9,330
-100 Reduced 1.38%
7,122 $578,000
Q2 2019

Jul 24, 2019

BUY
$73.44 - $82.41 $7,344 - $8,241
100 Added 1.4%
7,222 $591,000
Q3 2018

Oct 22, 2018

BUY
$70.71 - $77.75 $7,070 - $7,775
100 Added 1.42%
7,122 $549,000
Q1 2018

Apr 26, 2018

SELL
$62.56 - $72.26 $44,480 - $51,376
-711 Reduced 9.19%
7,022 $457,000
Q3 2017

Oct 25, 2017

BUY
$59.5 - $64.61 $460,113 - $499,629
7,733
7,733 $485,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Duncker Streett & CO Inc Portfolio

Follow Duncker Streett & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.